| | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
---|
What is an ATC-Code? | ATC-Overview |
|
| | IP | CI | | Ebvallo | | PR | PR | k.A. | | | Pierre Fabre Pharma SA | A | FB | | G |  |
L | | IP | | | Vegzelma 100 mg/4 ml | | 257.57 | 296.55 | 10 % | | Concentrate for infusion: Bevacizumabum 100mg / 4ml | iQone Healthcare Switzerland SA | A / SL | FB | | G |  |
L | | IP | | | Vegzelma 400 mg/16 ml | | 962.84 | 1063.55 | 10 % | | Concentrate for infusion: Bevacizumabum 400mg / 16ml | iQone Healthcare Switzerland SA | A / SL | FB | | G |  |
L | | IP | | PP | Herceptin subkutan 600mg/5ml | | 1484.04 | 1630.40 | 10 % | | Lösung zur subkutanen Injektion: Trastuzumabum 600mg / 5ml | Roche Pharma (Schweiz) AG | A / SL | FB | | G |  |
L | | IP | | | Ogivri 150 mg | | 456.84 | 513.25 | 10 % | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Trastuzumabum 150 mg | Medius AG | A / SL | FB | | G |  |
| | IP | CI | | Bilaxten 6 mg / ml | 5 ml | PR | PR | k.A. | | Eye drops: Bilastinum 6 mg/ml | A. Menarini GmbH | B | FB | | G |  |
| | IP | CI | | Regaine 2 % | 60 ml | PR | PR | k.A. | | Solution: Minoxidilum 20 mg/ml | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | CI | | Regaine 2 % | 3 x 60 ml | PR | PR | k.A. | | Solution: Minoxidilum 20 mg/ml | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | CI | | Regaine 5 % | 60 ml | PR | PR | k.A. | | Solution: Minoxidilum 50 mg/ml | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | CI | | Regaine 5 % | 3 x 60 ml | PR | PR | k.A. | | Solution: Minoxidilum 50 mg/ml | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | | | Mylotarg 5 mg | | PR | PR | k.A. | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Gemtuzumabum Ozogamicinum 5 mg | Pfizer AG | A | FB | | G |  |
|
| | IP | | | Nicorette Polar Mint 2 mg | 80 | PR | PR | k.A. | | Lozenges: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
| | IP | CI | | Nicotinell Fruit 2 mg | 12 piece(s) | PR | PR | k.A. | | Chewing Gum: Nicotinum 2 mg | Haleon Schweiz AG | D | FB | | G |  |
| | IP | CI | | Nicotinell Cool Mint 2 mg | 12 piece(s) | PR | PR | k.A. | | Chewing Gum: Nicotinum 2 mg | Haleon Schweiz AG | D | FB | | G |  |
| | IP | CI | | Nicotinell Fruit 2 mg | 24 piece(s) | PR | PR | k.A. | | Chewing Gum: Nicotinum 2 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | IP | CI | | Nicotinell Cool Mint 2 mg | 24 piece(s) | PR | PR | k.A. | | Chewing Gum: Nicotinum 2 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | IP | CI | | Nicotinell Fruit 2 mg | 96 piece(s) | PR | PR | k.A. | | Chewing Gum: Nicotinum 2 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | IP | CI | | Nicotinell Cool Mint 2 mg | 96 piece(s) | PR | PR | k.A. | | Chewing Gum: Nicotinum 2 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | IP | CI | | Nicotinell Fruit 2 mg | 204 piece(s) | PR | PR | k.A. | | Chewing Gum: Nicotinum 2 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | IP | CI | | Nicotinell Cool Mint 2 mg | 204 piece(s) | PR | PR | k.A. | | Chewing Gum: Nicotinum 2 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | IP | CI | | Nicotinell Fruit 4 mg | 12 piece(s) | PR | PR | k.A. | | Chewing Gum: Nicotinum 4 mg | Haleon Schweiz AG | D | FB | | G |  |
| | IP | CI | | Nicotinell Cool Mint 4 mg | 12 piece(s) | PR | PR | k.A. | | Chewing Gum: Nicotinum 4 mg | Haleon Schweiz AG | D | FB | | G |  |
| | IP | CI | | Nicotinell Fruit 4 mg | 24 piece(s) | PR | PR | k.A. | | Chewing Gum: Nicotinum 4 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | IP | CI | | Nicotinell Cool Mint 4 mg | 24 piece(s) | PR | PR | k.A. | | Chewing Gum: Nicotinum 4 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | IP | CI | | Nicotinell Fruit 4 mg | 96 piece(s) | PR | PR | k.A. | | Chewing Gum: Nicotinum 4 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | IP | CI | | Nicotinell Cool Mint 4 mg | 96 piece(s) | PR | PR | k.A. | | Chewing Gum: Nicotinum 4 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | IP | CI | | Nicorette Polar Mint 2 mg | 20 | PR | PR | k.A. | | Lozenges: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
| | IP | | | Nicorette Polar Mint 2 mg | 80 | PR | PR | k.A. | | Lozenges: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | CI | | Nicotinell Mint 1 mg | 36 Tablet(s) | PR | PR | k.A. | | Lozenges: Nicotinum 1 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | IP | CI | | Nicotinell Mint 1 mg | 96 Tablet(s) | PR | PR | k.A. | | Lozenges: Nicotinum 1 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | IP | CI | | Nicotinell Mint 1 mg | 204 Tablet(s) | PR | PR | k.A. | | Lozenges: Nicotinum 1 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | IP | CI | | Nicotinell Mint 2 mg | 36 Tablet(s) | PR | PR | k.A. | | Lozenges: Nicotinum 2 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | IP | CI | | Nicotinell Mint 2 mg | 96 Tablet(s) | PR | PR | k.A. | | Lozenges: Nicotinum 2 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | IP | CI | | Nicotinell Mint 2 mg | 204 Tablet(s) | PR | PR | k.A. | | Lozenges: Nicotinum 2 mg | Haleon Schweiz AG | D | FB | | G |  |
| | IP | CI | | Nicorette Microtab Original-Aroma | 100 Tablet(s) | PR | PR | k.A. | | Sublingual tablets: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | CI | | Nicorette Invisi 10 mg/16 h | 14 plaster(s) | PR | PR | k.A. | | Transdermal System: Nicotinum 15.75 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | CI | | Nicorette Invisi 15 mg/ 16 h | 14 plaster(s) | PR | PR | k.A. | | Transdermal System: Nicotinum 23.62 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | CI | | Nicorette Invisi 25 mg/ 16 h | 14 plaster(s) | PR | PR | k.A. | | Transdermal System: Nicotinum 39.37 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | CI | | Nicorette 10 mg | 42 piece(s) | PR | PR | k.A. | | Inhaler: Nicotinum 10 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | CI | | Nicotinell | 7 plaster(s) | PR | PR | k.A. | | Pflaster Stärke: Nicotinum 17.5 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | IP | CI | | Nicotinell | 21 plaster(s) | PR | PR | k.A. | | Pflaster Stärke: Nicotinum 17.5 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | IP | CI | | Nicotinell | 7 plaster(s) | PR | PR | k.A. | | Pflaster Stärke: Nicotinum 35 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | IP | CI | | Nicotinell | 21 plaster(s) | PR | PR | k.A. | | Pflaster Stärke: Nicotinum 35 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | IP | CI | | Nicotinell | 7 plaster(s) | PR | PR | k.A. | | Pflaster Stärke: Nicotinum 52.5 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | IP | CI | | Nicotinell | 21 plaster(s) | PR | PR | k.A. | | Pflaster Stärke: Nicotinum 52.5 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | IP | CI | | Nicorette Mint | | PR | PR | k.A. | | Spray zur Anwendung in der Mundhöhle: Nicotinum 1 mg | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
| | IP | | | Nicorette Fruit & Mint | | PR | PR | k.A. | | Spray zur Anwendung in der Mundhöhle: Nicotinum 1 mg | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
| | IP | CI | | Nicorette Mint | 2 | PR | PR | k.A. | | Spray zur Anwendung in der Mundhöhle: Nicotinum 1 mg | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
| | IP | | | Nicorette Fruit & Mint | 2 | PR | PR | k.A. | | Spray zur Anwendung in der Mundhöhle: Nicotinum 1 mg | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
| | IP | CI | | Nicorette Original-Aroma 2 mg | 30 Tablet(s) | PR | PR | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | CI | | Nicorette Freshfruit 2 mg | 30 Tablet(s) | PR | PR | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | CI | | Nicorette Polar Mint 2 mg | 30 Tablet(s) | PR | PR | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | CI | | Nicorette Original-Aroma 2 mg | 105 Tablet(s) | PR | PR | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | CI | | Nicorette Freshfruit 2 mg | 105 Tablet(s) | PR | PR | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | CI | | Nicorette Polar Mint 2 mg | 105 Tablet(s) | PR | PR | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | CI | | Nicorette Freshfruit 2 mg | 210 Tablet(s) | PR | PR | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
| | IP | CI | | Nicorette Polar Mint 2 mg | 210 Tablet(s) | PR | PR | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | CI | | Nicorette Original-Aroma 4 mg | 30 Tablet(s) | PR | PR | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 4 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | CI | | Nicorette Freshfruit 4 mg | 30 Tablet(s) | PR | PR | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 4 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | CI | | Nicorette Polar Mint 4 mg | 30 Tablet(s) | PR | PR | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 4 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | CI | | Nicorette Original-Aroma 4 mg | 105 Tablet(s) | PR | PR | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 4 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | CI | | Nicorette Freshfruit 4 mg | 105 Tablet(s) | PR | PR | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 4 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | CI | | Nicorette Polar Mint 4 mg | 105 Tablet(s) | PR | PR | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 4 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | | | | Nicotimed | 7 plaster(s) | PR | PR | k.A. | | Transdermal System: Nicotinum 17.5 mg | NOVARTIS CONSUMER HEALTH SCHWEIZ AG | C | FB | | G |  |
| | | | | Nicotimed | 21 plaster(s) | PR | PR | k.A. | | Transdermal System: Nicotinum 17.5 mg | NOVARTIS CONSUMER HEALTH SCHWEIZ AG | C | FB | | G |  |
| | | | | Nicotimed | 7 plaster(s) | PR | PR | k.A. | | Transdermal System: Nicotinum 35 mg | NOVARTIS CONSUMER HEALTH SCHWEIZ AG | C | FB | | G |  |
| | | | | Nicotimed | 21 plaster(s) | PR | PR | k.A. | | Transdermal System: Nicotinum 35 mg | NOVARTIS CONSUMER HEALTH SCHWEIZ AG | C | FB | | G |  |
| | | | | Nicotimed | 7 plaster(s) | PR | PR | k.A. | | Transdermal System: Nicotinum 52.5 mg | NOVARTIS CONSUMER HEALTH SCHWEIZ AG | C | FB | | G |  |
| | | | | Nicotimed | 21 plaster(s) | PR | PR | k.A. | | Transdermal System: Nicotinum 52.5 mg | NOVARTIS CONSUMER HEALTH SCHWEIZ AG | C | FB | | G |  |